相关实验视频
Updated: Jan 16, 2026
08:47
Oral Health Assessment by Lay Personnel for Older Adults
Published on: February 2, 2020
13.4K
加拿大三个省份的初级保健老年人的特征
Alexandra Whate1, Jacobi Elliott2, Sara Mallinson3
1School of Public Health Sciences, University of Waterloo, Waterloo, ON, Canada.
Canadian journal on aging = La revue canadienne du vieillissement
|January 15, 2026
概括
这项研究描述了加拿大初级保健中的老年人,发现了诸如高血压和骨关节炎等常见疾病. 许多老年人很脆弱,女性报告更多的疼痛和较低的社会经济地位.
科学领域:
- 老年学是一门学科.
- 初级医疗保健医学 一级医疗保健医学
- 公共卫生 公共卫生
背景情况:
- 了解初级保健中老年人的健康状况对于有针对性的计划开发至关重要.
- 初级保健机构为大量且日益增长的老年人提供服务.
研究的目的:
- 在加拿大三个省份划分使用初级保健服务的老年人 (70岁及以上) 的人口统计和健康特征.
- 建立有关该人口慢性疾病,脆弱性和生活质量的基线数据.
主要方法:
- 对594名参与者进行了一项调查,收集有关人口统计,医疗保健利用,慢性疾病和生活质量 (EQ-5D-5L) 的数据.
- 使用赤字积累脆弱指数 (FI) 量化评估脆弱性.
主要成果:
- 最常见的慢性疾病包括高血压 (51.1%),关节炎 (37.2%),糖尿病 (22.8%) 和心脏病 (21.8%).
- 平均虚弱指数 (FI) 为0.153,其中22.9%的参与者被确定为虚弱 (FI>0.21).
- 女性报告疼痛/不适和焦虑/抑郁程度较高,教育程度和收入较低,尽管自我评估的健康状况与男性相似.
结论:
- 该研究为医疗保健提供者和政策制定者提供了有价值的基准数据,为老年人群规划初级保健服务.
- 这些发现凸显了针对老年人获得初级保健的常见慢性疾病和脆弱性的定制干预措施的必要性.
相关概念视频
01:29Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
01:15Drug Dosing: Geriatric Patients
225
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
225
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
187
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
187
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
196
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
196
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
234
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
234